Proto-Oncogene Proteins c-bcl-6
-
Subject Areas on Research
- A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.
- Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases.
- Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
- Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2.
- EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study.
- Endometrial BCL6 Overexpression in Eutopic Endometrium of Women With Endometriosis.
- Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.
- Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells.
- Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.
- IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF.
- Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
- KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance.
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
- Lymphomatosis Cerebri: A Diagnostic Challenge.
- Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
- PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
- Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene.
- Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein.
- Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
- The polyphony of BACH2.
- The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment.
- Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.